September 11th, 2019
New startup BOA Biomedical launches to reduce sepsis deaths
Platform technology can rapidly diagnose and treat a broad range of antibiotic-resistant infectious diseases
News
Tag: Don Ingber
October 8th, 2015
Harvard's Wyss Institute launches Opsonix to commercialize pathogen-extracting sepsis therapy
New startup, licensing Harvard technology, seeks to develop an extracorporeal medical device that removes infectious pathogens and toxins from circulating blood of sepsis patients.
